Stimulating hypothalamus restores walking in paralyzed patients: « Researchers at EPFL and Lausanne University Hospital (CHUV) have achieved a major milestone in the treatment of spinal cord injuries (SCI). »
U of A Cancer Center clinical trial advances research in treatment of biliary tract cancers - EurekAlert
Nipah virus: epidemiology, pathogenesis, treatment, and prevention - EurekAlert
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
Hidden Mutation Discovered in Aggressive Bone Cancer Could Revolutionize Treatment
AI predicts cancer prognoses, responses to treatment
Never-before-seen parasite is resistant to ivermectin: Trichuris incognita is a newfound intestinal roundworm closely related to the whipworm parasite. However, it is significantly more resistant to treatment.
“Heartbreaking” impact of Covid on treatment of children with brain tumors - EurekAlert
How a Simple Nasal Swab Is Changing Asthma Diagnosis and Treatment for Kids
First successful clinical trial of VU319 brings Alzheimer's treatment one step closer
Development of tau phosphorylation-targeting therapies for the treatment of neurodegenerative diseases - EurekAlert
Study Says Psychedelics "May Hold Potential as a Safe and Effective Treatment for Bipolar Disorder"
NIH Debunks the Myth: Treatment Isn’t the Only Key to Reducing Cancer Deaths
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment
Imaging technique allows rapid assessment of ovarian cancer subtypes and their response to treatment - EurekAlert
World’s 1st donor cell therapy helps 3 autoimmune disorder patients in China: « Three Chinese patients, one woman and two men, were the first to receive treatment for autoimmune disorders using engineered immune cells made from donor cells. »
NHS rolls out monoclonal antibody Crysvita (burosumab) treatment for rare bone disease
Monoclonal antibody benralizumab, given during some asthma and COPD attacks, is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%.
No 'one size fits all' treatment for Type 1 Diabetes
